Atherosclerotic disease, as a systemic process, affects all arteries to varying degrees. In particular,coexistent carotlid aria coronary artery diseases are common; Management of such patients has been a point of cont...Atherosclerotic disease, as a systemic process, affects all arteries to varying degrees. In particular,coexistent carotlid aria coronary artery diseases are common; Management of such patients has been a point of continuing controversy. Current American Heart Association （AHA） guidelines recommend carotid endarterectomy （CEA） in symptomatic patients with carotid artery stenosis of 50%-99% and in asymptomatic patients with stenosis of 60%-99%. Carotid artery stenting （CAS） has become a reasonable alternative to CEA, particularly in patients at high risk for CEA. We sought to assess feasibility, safety and midterm outcome of carotid artery stenting in patients with coexisting symptomatic coronary disease and carotid artery stenosis.展开更多
文摘Atherosclerotic disease, as a systemic process, affects all arteries to varying degrees. In particular,coexistent carotlid aria coronary artery diseases are common; Management of such patients has been a point of continuing controversy. Current American Heart Association （AHA） guidelines recommend carotid endarterectomy （CEA） in symptomatic patients with carotid artery stenosis of 50%-99% and in asymptomatic patients with stenosis of 60%-99%. Carotid artery stenting （CAS） has become a reasonable alternative to CEA, particularly in patients at high risk for CEA. We sought to assess feasibility, safety and midterm outcome of carotid artery stenting in patients with coexisting symptomatic coronary disease and carotid artery stenosis.
